Global News Feed
Home
Bookmarks
Preferences
World
Extract
Custom
Fetch
Install
Total
Unread
Saved
More
Preferences
Custom News
Fetch News
Install App
Home
Saved
World
Extract
More
Prev
Back to News
Next
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO
โ
Source:
Reuters
Category:
General
Region:
General
Published:
September 21, 2026 at 13:22
๐ Summary
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters
๐ Read Full Article at Reuters
โจ Extract Article
๐ค Share
๐ท๏ธ Keywords:
drug
developer
adarx
seeks
billion
valuation
reuters
๐ฌ Social Media Posts
๐ Refetch Posts
Searching social media for related posts...
Click "Fetch Related Posts" to find social media discussions about this article
๐ฐ Related Articles
EXCLUSIVE: Shein seeks $30-$40 billion valuation for August Hong Kong IPO, sources say
Reuters
ยท
Aug 04
Databricks secures funding round at $188 billion valuation
Reuters
ยท
Jul 17
Novo-backed Windward Bio targets $1 billion valuation in US IPO
Reuters
ยท
Nov 09
German startup 1Komma5Grad secures $1.35 billion valuation in new financing round
Reuters
ยท
Oct 12
Previous Article
Next Article